Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study

Nilsson, S., Cislo, P., Sartor, O. et al. (7 more authors) (2016) Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study. Annals of Oncology, 27 (5). pp. 868-874. ISSN 0923-7534

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Keywords: castration-resistant prostate cancer; health-related quality of life; patient-reported outcomes; radium-223 dichloride; α-emitter
Dates:
  • Published: May 2016
  • Accepted: 9 February 2016
  • Published (online): 23 February 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 29 Nov 2016 11:51
Last Modified: 29 Nov 2016 12:01
Published Version: http://dx.doi.org/10.1093/annonc/mdw065
Status: Published
Publisher: Oxford University Press
Refereed: Yes
Identification Number: https://doi.org/10.1093/annonc/mdw065

Share / Export

Statistics